Showing results (1791-1800 of 1,914) with videos related to
Sort By:
Pageof 192
Archives of Neurology|October 12, 2005
Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adultsMark A Fishel, G Stennis Watson, Thomas J Montine, et al.JAMA Neurology|June 20, 2013
Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trialAngela J Hanson, Jennifer L Bayer-Carter, Pattie S Green, et al.Investigative Ophthalmology & Visual Science|March 22, 2017
Novel 25 kb Deletion of MERTK Causes Retinitis Pigmentosa With Severe ProgressionDaniel R Evans, Jane S Green, Gordon J Johnson, et al.Journal of Cheminformatics|February 23, 2021
MAIP: a web service for predicting blood-stage malaria inhibitorsNicolas Bosc, Eloy Felix, Ricardo Arcila, et al.Heart Rhythm|April 27, 2005
Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective "frosty" trialPeter L Friedman, Marc Dubuc, Martin S Green, et al.Nature|May 21, 2010
Thousands of chemical starting points for antimalarial lead identificationFrancisco-Javier Gamo, Laura M Sanz, Jaume Vidal, et al.Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|October 2, 2022
Pain Interference in End Stage Kidney Disease is Associated with Changes in Gut Microbiome Features Before and After Kidney TransplantationMark B Lockwood, George E Chlipala, Mark Maeinschein-Cline, et al.Journal of Clinical and Translational Science|April 27, 2026
Return of results is important to heterogeneous research participants: A single-site surveySheila M O'Byrne, Ismael Castaneda, Rayheann-NaDeja Collins, et al.Frontiers in Immunology|December 25, 2012
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneCarl K Edwards, Julie S Green, Hans-Dieter Volk, et al.Pageof 192